StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for OPCH yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $19.62 | $19.69 | +0.36% | 2.9M |
| 05-19 | $19.62 | $20.86 | +6.32% | 6.7M |
| 05-20 | $20.86 | $22.23 | +6.57% | 5.2M |
| 05-21 | $22.05 | $21.52 | -2.40% | 2.8M |
| 05-22 | $21.52 | $20.93 | -2.74% | 2.5M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $5.65B | $4.18B | $2.75B | $5.00B |
Operating Income | $337.91M | $246.41M | $161.90M | $321.83M |
Net Income | $207.59M | $149.08M | $50.52M | $211.82M |
EPS (Diluted) | $1.27 | $0.91 | $0.59 | $1.23 |
Total Assets | $3.46B | $3.48B | $3.38B | $3.42B |
Total Liabilities | $2.13B | $2.12B | $2.02B | $2.02B |
Cash & Equivalents | $232.62M | $309.82M | $198.82M | $412.56M |
Free Cash Flow OCF − CapEx | $217.14M | $194.90M | $64.65M | $287.79M |
Shares Outstanding | 156.86M | 160.11M | 162.29M | 166.26M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.